February 25, 2021
Business News

Half-year report on the Sensorion liquidity contract with Kepler Cheuvreux


MONTPELLIER, France–()–Regulatory News:

Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, issued the half-year report on its liquidity contract with Kepler Chevreux.

As of December 31, 2020, the following assets appeared on the liquidity account :

Sensorion ordinary shares :

67 975

Amount :

33 243,51 €

It is reminded that as of June 30, 2020, the following assets appeared on the liquidity account :

Sensorion ordinary shares :

80 107

Amount :

8 849,38 €

About Sensorion

Sensorion is a pioneering…



Click here to view the original article.

Related Posts

You might also like ...

Confluent Names Lara Caimi to Its Board of Directors
Enexor Wins UNWTO Global Startup Competition
Sanderson Farms to Participate in Stephens Virtual Best Ideas Conference